IBDEI14W ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18210,0)
 ;;=99367^^89^916^1^^^^1
 ;;^UTILITY(U,$J,358.3,18210,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18210,1,2,0)
 ;;=2^TEAM CONF W/O PT BY PHYS
 ;;^UTILITY(U,$J,358.3,18210,1,3,0)
 ;;=3^99367
 ;;^UTILITY(U,$J,358.3,18211,0)
 ;;=99368^^89^916^2^^^^1
 ;;^UTILITY(U,$J,358.3,18211,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18211,1,2,0)
 ;;=2^TEAM CONF W/O PT BY PHYS AND NONPHYS QHP
 ;;^UTILITY(U,$J,358.3,18211,1,3,0)
 ;;=3^99368
 ;;^UTILITY(U,$J,358.3,18212,0)
 ;;=99507^^89^917^22^^^^1
 ;;^UTILITY(U,$J,358.3,18212,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18212,1,2,0)
 ;;=2^HOME VISIT CATH MAINTAIN
 ;;^UTILITY(U,$J,358.3,18212,1,3,0)
 ;;=3^99507
 ;;^UTILITY(U,$J,358.3,18213,0)
 ;;=99509^^89^917^21^^^^1
 ;;^UTILITY(U,$J,358.3,18213,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18213,1,2,0)
 ;;=2^HOME VISIT ADL TRAINING
 ;;^UTILITY(U,$J,358.3,18213,1,3,0)
 ;;=3^99509
 ;;^UTILITY(U,$J,358.3,18214,0)
 ;;=99510^^89^917^24^^^^1
 ;;^UTILITY(U,$J,358.3,18214,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18214,1,2,0)
 ;;=2^HOME VISIT SING/M/FAM COUNS
 ;;^UTILITY(U,$J,358.3,18214,1,3,0)
 ;;=3^99510
 ;;^UTILITY(U,$J,358.3,18215,0)
 ;;=99511^^89^917^23^^^^1
 ;;^UTILITY(U,$J,358.3,18215,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18215,1,2,0)
 ;;=2^HOME VISIT FECAL/ENEMA MGMT
 ;;^UTILITY(U,$J,358.3,18215,1,3,0)
 ;;=3^99511
 ;;^UTILITY(U,$J,358.3,18216,0)
 ;;=99601^^89^917^20^^^^1
 ;;^UTILITY(U,$J,358.3,18216,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18216,1,2,0)
 ;;=2^HOME INFUSION/VISIT 2 HRS
 ;;^UTILITY(U,$J,358.3,18216,1,3,0)
 ;;=3^99601
 ;;^UTILITY(U,$J,358.3,18217,0)
 ;;=99602^^89^917^19^^^^1
 ;;^UTILITY(U,$J,358.3,18217,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18217,1,2,0)
 ;;=2^HOME INFUSION,EA ADDL HR
 ;;^UTILITY(U,$J,358.3,18217,1,3,0)
 ;;=3^99602
 ;;^UTILITY(U,$J,358.3,18218,0)
 ;;=10061^^89^917^25^^^^1
 ;;^UTILITY(U,$J,358.3,18218,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18218,1,2,0)
 ;;=2^I&D ABSCESS,COMPLICATED
 ;;^UTILITY(U,$J,358.3,18218,1,3,0)
 ;;=3^10061
 ;;^UTILITY(U,$J,358.3,18219,0)
 ;;=10060^^89^917^26^^^^1
 ;;^UTILITY(U,$J,358.3,18219,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18219,1,2,0)
 ;;=2^I&D ABSCESS,SIMPLE
 ;;^UTILITY(U,$J,358.3,18219,1,3,0)
 ;;=3^10060
 ;;^UTILITY(U,$J,358.3,18220,0)
 ;;=11000^^89^917^8^^^^1
 ;;^UTILITY(U,$J,358.3,18220,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18220,1,2,0)
 ;;=2^DEBRIDE ECZEMA/INFECTED SKIN UP TO 10%
 ;;^UTILITY(U,$J,358.3,18220,1,3,0)
 ;;=3^11000
 ;;^UTILITY(U,$J,358.3,18221,0)
 ;;=11042^^89^917^14^^^^1
 ;;^UTILITY(U,$J,358.3,18221,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18221,1,2,0)
 ;;=2^DEBRIDE TISSUE,FIRST 20 SQ CM
 ;;^UTILITY(U,$J,358.3,18221,1,3,0)
 ;;=3^11042
 ;;^UTILITY(U,$J,358.3,18222,0)
 ;;=11200^^89^917^34^^^^1
 ;;^UTILITY(U,$J,358.3,18222,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18222,1,2,0)
 ;;=2^REMOVAL OF SKIN TAGS UP TO 15
 ;;^UTILITY(U,$J,358.3,18222,1,3,0)
 ;;=3^11200
 ;;^UTILITY(U,$J,358.3,18223,0)
 ;;=11400^^89^917^16^^^^1
 ;;^UTILITY(U,$J,358.3,18223,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18223,1,2,0)
 ;;=2^EXCISION LESION TRUNK/ARM/LEG
 ;;^UTILITY(U,$J,358.3,18223,1,3,0)
 ;;=3^11400
 ;;^UTILITY(U,$J,358.3,18224,0)
 ;;=11420^^89^917^15^^^^1
 ;;^UTILITY(U,$J,358.3,18224,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18224,1,2,0)
 ;;=2^EXCISION LESION NECK/HAND/FOOT
